Biotech · Private company
Katmai Pharmaceuticals Inc.
Track this companyFree. Adds Katmai Pharmaceuticals Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- ERAS-801Phase 1 · Glioblastoma MultiformeClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- A Study to Evaluate ERAS-801 in Patients With Recurrent Glioblastoma (THUNDERBBOLT-1)PHASE1 · ACTIVE_NOT_RECRUITING · started Feb 25, 2022ClinicalTrials.gov NCT05222802 · fetched Nov 12, 2026